Phase 3 study of YM060 in patients with diarrhea-predominant irritable bowel syndrome (d-IBS).

Trial Profile

Phase 3 study of YM060 in patients with diarrhea-predominant irritable bowel syndrome (d-IBS).

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Oct 2015

At a glance

  • Drugs Ramosetron (Primary)
  • Indications Irritable bowel syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Oct 2006 Status change
    • 19 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top